ch. 9 and 10

pharmacokinetics

Extracellular

Intracellular

peak effect

oxidation

Antitoxin

biotransformation

Toxicology

dose

FDA

4

1

salmonella

D

Hepatitis A

OSHA

prevention

4

B

Centers for disease control and prevention

CDC

OSHA

World Health Organization

WHO

HHS

BSL-1

noise

Type A

Type B

Type C

Type D

Pharmacodynamics

Pharmacokinetics

Pharmacotherapeutics

Toxicology

Pharmacy

pharmacognosy

chemical

Dilantin

analgesics

aspirin

absorption

bioavailability

extracellular

cellular

distribution

Biotransformation

Phase I reactions

dose

dosage

Therapeutic index

latency

Chronic

Schedule I

first pass effect

Toxic effects

Starvation

Age

Genetics

Gender

Circadian rhythms

cyanide

mercury

lead